Mohammad Shahbazi

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy”.

Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy

Cancer Medicine(2022)10.1002/cam4.4644

N/A

0DataRank · unranked

25 citations

Matthew R. Trendowski, Emma Wilkinson, Mohammad Shahbazi, Paul C. Dinh, Megan M. Shuey +14 more

Building a model to predict the risk of multiple severe neurotoxicities in cancer survivors after cisplatin treatment.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.e24066

N/A

0DataRank · unranked

1 citations

Megan M. Shuey, Mohammad Shahbazi, Matthew R. Trendowski, Paul C. Dinh, Darren R. Feldman +10 more

Comparison of GWAS results between de novo tinnitus and cancer treatment-related tinnitus suggests distinctive roles for genetic risk factors

Scientific Reports(2024)10.1038/s41598-024-78274-w

N/A

0DataRank · unranked

1 citations

Heather E. Wheeler, Gregory T. Armstrong, Robert D. Frisina, Lois B. Travis, M. Eileen Dolan +1 more

Comparison of associations suggests mainly distinct pools of genetic risk factors contribute to cisplatin-induced hearing loss and hearing difficulty in the general population

Frontiers in Pharmacology(2025)10.3389/fphar.2025.1577072

N/A

0DataRank · unranked

0 citations

Heather E. Wheeler, Xindi Zhang, Robert D. Frisina, Lois B. Travis, M. Eileen Dolan +1 more